According to InMed Pharmaceuticals latest financial reports the cash on hand of INM is $8.91M, an increase of 43.25% to 2022. At the end of 2022 company had $6.22M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $8.91M | 43.25% |
2022 | $6.22M | -16.03% |
2021 | $7.41M | 69.84% |
2020 | $4.36M | -57.92% |
2019 | $10.37M | - |